Failure of β-cell function for compensate variation in insulin sensitivity in hypomagnesemic subjects

Magnesium Research

Volumn 22, Issue 3, 2009, Pages 151-156

  Simental Mendía, Luis E ^a,b   Rodríguez Morán, Martha ^a,b   Guerrero Romero, Fernando ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Research Group on Diabetes and Chronic Illnesses   (Mexico)

Author keywords

Beta cell function; Insulin sensitivity; Magnesium

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; PANCREAS ISLET BETA CELL; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 70349542540     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2009.0180     Document Type: Article

References (35)

1. Lopez Martínez J, Sanchez Castilla M, García de Lorenzo y Mateos A, Culebras Fernandez JM. Magnesium: metabolism and requeriments. Nutr Hosp 1997: 4-14.
2. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997; 10: 346-55.
3. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 1999; 159: 2151-9.
4. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993; 21: 1024-9.
5. Paolisso G, Scheen A, D'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990; 33: 511-4.
6. TosielloL. Hypomagnesemia and diabetes mellitus. Areview of clinical implications. Arch Intern Med 1996; 156: 1143-8.
7. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-40.
8. Guerrero-Romero F, Rascón-Pacheco RA, Rodríguez-Morán M, de la Peña JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008; 38: 389-96.
9. Rodríguez-Morán M, Guerrero-Romero F. Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects: Arandomized double-blind controlled trial. Diabetes Care 2003; 26: 1147-52.
10. Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ. Dairy, Magnesium, and Calcium Intake in Relation to Insulin Sensitivity: Approaches to Modeling a Dose-dependent Association. Am J Epidemiol 2006; 164: 449-58.
11. Paolisso G, Scheen A, Cozzolino D, Di Mario G, Varricchio M, D'Onofrio F, Lefebvre P. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510-4.
12. Lefebvre PJ, Paolisso G, Scheen AJ. Magnesium and glucose metabolism. Therapie 1994; 49: 1-7.
13. Sheehan JP. Magnesium deficiency and diabetes mellitus. Magnes Trace Elem 1991; 10: 215-9.
14. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, etal. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 1993; 42: 1663-72.
15. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: 787-94.
16. KahnSE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19.
17. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C, etal. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospectives studies of Pima Indians. N Engl J Med 1993; 329: 1988-92.
18. Cavaghan MK, Ehrmann DA, Polonsky K. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000; 106: 329-33.
19. Guerrero F, Rodríguez M. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 2006; 36: 796-802.
20. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of β-cell function. The hyperbolic correction. Diabetes 2002; 51: S212-S220.
21. Belfiore F, Lannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998; 63: 134-41.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher D F, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
23. The Seventh Report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
24. Shargel L, Wu-Pong S, Yu ABC. Review of mathematical fundamentals. In: Applied Biopharmaceutics and Pharmacokinetics. New York: McGraw-Hill, 2004: 21-51.
25. Bergman RN, Philips LS, Cobelli C. Physiologic evaluation of factors controlling glucose disposition in man: measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456-67.
26. Yajnik CS, Smith RF, Hockaday TDR, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J (Clin Res Ed) 1984; 288: 1032-4.
27. Paolisso G, Sgambato S, Giuglinao D, Torella R, Varicchio M, Scheen AJ, D'Onofrio F, Lefebvre PJ. Impaired insulin mediated erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988; 31: 910-5.
28. Dzurik R, Stefikova K, Spustova V, Fetkovska N. The role of magnesium deficiency in insulin resistance: an in vitro study. J Hypertens 1991; 9: S312-S313.
29. Guerrero-Romero F, Rodríguez-Morán M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int Obes Relat Metab Disord 2002; 26: 469-74.
30. Rosolova H, Mayer Jr O, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Endocrinol Metab 1997; 82: 3783-5.
31. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of β-cell function. The hyperbolic correction. Diabetes 2002; 51 (Suppl. 1): S212-S220.
32. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456-67.
33. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP, etal. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796-803.
34. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004; 47: 943-56.
35. Reinhart R, Marx J, Haas R, Desbiens N. Intracellular magnesium of mononuclear cells from venous blood of clinical healthy subjects. Clin Chem Acta 1987; 48: 2415-20.